Shandong Weigao Group Medical Polymer Co Ltd (1066.HK) stock: key figures, P/E, revenue and dividend

Health Care · China · ISIN CNE100000171

Price
2.81 HKD
Market cap
12.74 bn HKD
P/E (2025)
7.73
P/S (2025)
0.93
Dividend yield
5.12 %
Net margin
12.04 %
Return on equity (ROE)
6.38 %
Return on assets (ROA)
4.57 %

Shandong Weigao Group Medical Polymer Co Ltd financials

Fiscal year20242025
Revenue12.44 bn CNY13.69 bn CNY
Gross profit6.26 bn CNY6.47 bn CNY
EBIT2.16 bn CNY1.81 bn CNY
Net income1.96 bn CNY1.65 bn CNY
Diluted EPS – continuing operations0.43 CNY0.36 CNY

Full history since 2001, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Shandong Weigao Group Medical Polymer Co Ltd

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; pharma packaging products comprising prefilled drug delivery system, pharmaceutical packaging consumables, and automatic drug delivery systems; and orthopedic products that include spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. It also provides interventional products, such as tumor, vascular, and nursing interventions, as well as blood management products, including whole blood collection consumables and blood transfusion equipment. In addition, the company manufactures and sells medical PVC granules, plastic packing bags, and carton boxes; manufacture and sale of medical polymer materials and products; injection puncture instruments; computer technical services; and X-ray based irradiation machines. Further, it provides finance leasing, factoring, and consulting services. The company was founded in 1988 and is based in Weihai, the People's Republic of China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.